TGFB1 and colorectal carcinoma: Our study suggests a strategy of using 68Ga-FAPI PET/CT imaging–guided precise TGF-β inhibition to sensitize metastatic CRC to immunotherapy, and highlights the necessity of using double-tracer PET/CT imaging with 68Ga-FAPI and 18F-FDG for the management of patients with CRC.